Notices. Notice
399 words·~2 min read·
/register/2019/10/25/2019-23251A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4164-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA-2018-N-3163; FDA-2012-D-0429; FDA-2012-D-0049; FDA-2018-N-3031; FDA-2011-D-0125; FDA-2018-N-4428; FDA-2012-N-0560; FDA-2010-N-0414; FDA-2012-N-1203; and FDA-2019-N-0430] Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA or Agency) is publishing a list of information collections that have been approved by the Office of Management and Budget
(OMB)under the Paperwork Reduction Act of 1995 (PRA). FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, *PRAStaff@fda.hhs.gov.* SUPPLEMENTARY INFORMATION: The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at *http://www.reginfo.gov/public/do/PRAMain.* An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Table 1—List of Information Collections Approved by OMB Title of collection OMB control No. Date approval expires Physician Interpretation of Information About Prescription Drugs in Scientific Publications Versus Promotional Pieces 0910-0875 9/30/2021 Guidance on Meetings with Industry and Investigators on the Research and Development of Tobacco Products 0910-0731 8/31/2022 Reporting Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke Under the Federal Food, Drug, and Cosmetic Act 0910-0732 8/31/2022 Tobacco Products, User Fees, Requirements for the Submission of Data Needed to Calculate User Fees for Domestic Manufacturers and Importers of Tobacco 0910-0749 8/31/2022 Guidance for Industry on Establishing That a Tobacco Product Was Commercially Marketed in the United States as of February 15, 2007 0910-0775 8/31/2022 Medicated Feed Mill License Application 0910-0337 9/30/2022 Guidance on Informed Consent for In Vitro Diagnostic Studies Using Leftover Human Specimens That Are Not Individually Identifiable 0910-0582 9/30/2022 Manufactured Food Regulatory Program Standards 0910-0601 9/30/2022 Information to Accompany Humanitarian Device Exemption Applications and Annual Distribution Number Reporting Requirements 0910-0661 9/30/2022 Generic Clearance for Quick Turnaround Testing of Communication Effectiveness 0910-0876 9/30/2022 Dated: October 17, 2019. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2019-23251 Filed 10-24-19; 8:45 am]
Connectionstraces to 1
Traces to 1 document